Skip to content
Multidisciplinary Association for Psychedelic Studies – MAPS

Multidisciplinary Association for Psychedelic Studies - MAPS

  • About
    • Our Mission
    • Our History
    • Our Team
    • Community Allies
  • Our Work
    • Advancing Research
    • Changing Policy
    • Evolving Education
    • The Virtual Trip
  • News
    • Updates
    • Newsletter
    • Press Releases
    • MAPS Bulletin
    • MAPS in the Media
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Volunteer
    • Careers
    • Community Events
    • Resources
    • Integration Station
    • Music Is the Bridge
  • Store
    • Learning
    • Apparel
    • Accessories
    • Bookshop
Login
  • Donate
0

Newsletters

Newsletter cover image

Newsletter: December 2017

MAPS Receives Donation from Two Cryptocurrency Philanthropists of 111 Bitcoin Worth $2 Million at Time of Donation December 22, 2017 Dear friends and supporters, The rapid progression of support for psychedelic …
Newsletter cover image

Newsletter: November 2017

MDMA Research Highlighted in Three Scientific Journals November 30, 2017 Dear friends and supporters, This month, three renowned scientific journals published information about MAPS-sponsored research …
Newsletter cover image

Newsletter: October 2017

Health Canada Clears Training Study of MDMA-Assisted Therapy for PTSD at Canadian Phase 3 Sites October 30, 2017 Dear friends and supporters, On October 4, 2017, Health Canada, the Canadian federal institution …
Newsletter cover image

Newsletter: September 2017

Study Initiation Visits Begin for Phase 3 Lead-In Trials of MDMA-Assisted Therapy for PTSD September 30, 2017 Dear friends and supporters, Psychedelic research is accelerating at an unprecedented rate.Last …
Newsletter cover image

Newsletter: August 2017

MDMA-Assisted Therapy for PTSD Receives Breakthrough Therapy Designation by FDA MAPS’ Phase 3 Program to Include Two Trials in 14 Locations August 30, 2017 Dear friends and supporters, On August …
Newsletter cover image

Newsletter: July 2017

MAPS Submits Breakthrough Therapy Designation Application to FDA for Phase 3 Trials of MDMA-Assisted Therapy for PTSD Zendo Project launches crowdfunding campaign to expand psychedelic peer support services …
Newsletter cover image

Newsletter: June 2017

FDA Comments on Special Protocol Assessment for Phase 3 Trials of MDMA-Assisted Therapy for PTSD The Zendo Project provides psychedelic peer support for over 260 guests at Lightning in a Bottle June 16, …
Newsletter cover image

Newsletter: May 2017

FDA and MAPS Agree on Protocol for Phase 3 Trials of MDMA-Assisted Therapy for PTSD Over 100 videos from Psychedelic Science 2017 are now online May 17, 2017 Dear friends and supporters, Psychedelic Science …
Newsletter cover image

Newsletter: April 2017

FDA Responds to Special Protocol Assessment for Phase 3 Clinical Trials Psychedelic Science 2017 conference tickets are now sold out April 15, 2017 Dear friends and supporters, Psychedelic Science 2017 …
Newsletter cover image

Newsletter: March 11, 2017

Completed: Second-Largest Trial of MDMA-Assisted Therapy for PTSD Tickets for Psychedelic Science 2017 are selling fast March 11, 2017 Dear friends and supporters, Our Phase 2 trials of MDMA-assisted psychotherapy …
Newsletter cover image

Newsletter: February 13, 2017

FDA Receives Protocol for Phase 3 Study of MDMA-Assisted Therapy for PTSD First participant enrolled in first-ever trial of marijuana for chronic PTSD in veterans With just 63 days left until Psychedelic …
Newsletter cover image

Newsletter: January 2017

2017: Together, We’re Making Medicines Psychedelic Science 2017 will feature 175+ presenters over six days January 12, 2017 Happy 2017 from the Multidisciplinary Association for Psychedelic Studies (MAPS)! …

Posts pagination

Previous Page Page 1 … Page 7 … Page 20 Next Page
Multidisciplinary Association for Psychedelic Studies – MAPS
  • About
    • Our Mission
    • Our History
    • Our Team
    • Financial Reports
    • Careers
    • Refunds & Returns
    • FAQs
    • Privacy Policy
    • Global Affiliates
  • Our Work
    • Psychedelic Fundamentals
    • The Virtual Trip
    • U.S. MDMA Therapy Education
    • Health Equity
    • Policy & Advocacy
  • Advancing Research
    • MDMA
    • Marijuana
    • LSD
    • Ibogaine
    • Ayahuasca
  • News
    • Updates
    • MAPS in the Media
    • MAPS Bulletin
    • MAPS Podcast
    • Monthly Newsletter
    • Press Releases
    • Newsroom
  • Take Action
    • MAPS Membership
    • Donate
    • Participate in a Trial
    • Events
    • Resources

Newsletter Sign Up

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn
  • Reddit
© 1986 - 2026 Multidisciplinary Association for Psychedelic Studies. All Rights Reserved. Disclaimer | Privacy Policy.
3141 Stevens Creek Blvd #40563, San Jose, CA 95117.
Mail checks to: MAPS P.O. Box 103004 Pasadena, CA 91189-3004.
Proudly powered by WordPress. Hosted by Pressable.

Download our Integration Guide

Just enter your email in order to download our Integration Guide